Syndrome News and Research

RSS
Are cattle at risk of SARS-CoV-2 infection?

Are cattle at risk of SARS-CoV-2 infection?

The antibody evasion properties of the SARS-CoV-2 Omicron subvariant BA.2.75

The antibody evasion properties of the SARS-CoV-2 Omicron subvariant BA.2.75

Novel age predictor helps investigate heterogeneity in brain aging

Novel age predictor helps investigate heterogeneity in brain aging

Study shows probability of getting COVID for mask wearers vs. non-mask wearers

Study shows probability of getting COVID for mask wearers vs. non-mask wearers

Hemopurifier containing Galanthus nivalis resin removes SARS-CoV-2 variants

Hemopurifier containing Galanthus nivalis resin removes SARS-CoV-2 variants

High prevalence of fungal secondary infections among COVID-19 patients

High prevalence of fungal secondary infections among COVID-19 patients

Further SARS-CoV-2 variants, and intermittent epidemics may become the 'new normal'

Further SARS-CoV-2 variants, and intermittent epidemics may become the 'new normal'

COVID pandemic stress and menstrual cycle changes

COVID pandemic stress and menstrual cycle changes

Human anti-desmoglein 2 levels are associated with COVID-19 severity

Human anti-desmoglein 2 levels are associated with COVID-19 severity

ADAR1 mutation sets off biochemical pathways that produce an organ-damaging autoimmune response

ADAR1 mutation sets off biochemical pathways that produce an organ-damaging autoimmune response

Vaccination and BA.1 breakthrough infection induce neutralizing antibodies less efficient against BA.4 and BA.5 Omicron variants

Vaccination and BA.1 breakthrough infection induce neutralizing antibodies less efficient against BA.4 and BA.5 Omicron variants

How can researchers profile post-COVID syndromes among distinct SARS-CoV-2 variants?

How can researchers profile post-COVID syndromes among distinct SARS-CoV-2 variants?

Adults aged ≥50 years boosted with SARS-CoV-2 mRNA vaccines less likely to experience adverse reactions after second booster than during initial booster

Adults aged ≥50 years boosted with SARS-CoV-2 mRNA vaccines less likely to experience adverse reactions after second booster than during initial booster

Lyme disease remains a growing public health concern in the United States, says FAIR Health study

Lyme disease remains a growing public health concern in the United States, says FAIR Health study

Study explores differential antibody-mediated effector functions evoked by two mRNA-based COVID-19 vaccines

Study explores differential antibody-mediated effector functions evoked by two mRNA-based COVID-19 vaccines

Plasma myosin light chain 9 levels may be better predictor of COVID-19 severity than blood biomarkers

Plasma myosin light chain 9 levels may be better predictor of COVID-19 severity than blood biomarkers

Long-term symptoms 23 months after SARS-CoV-2 infection

Long-term symptoms 23 months after SARS-CoV-2 infection

How does Omicron BA.1 infection impact the risk of reinfection with BA.5?

How does Omicron BA.1 infection impact the risk of reinfection with BA.5?

What are the hidden sources of SARS-CoV-2 evolution?

What are the hidden sources of SARS-CoV-2 evolution?

What is the efficacy of COVID-19 BNT162b2 and mRNA-1273 booster vaccinations?

What is the efficacy of COVID-19 BNT162b2 and mRNA-1273 booster vaccinations?